Effect of d,L-ETHIONINE (cas 13073-35-3) administration on the histomorphology of canine pancreatic acinar and β-cells
-
Add time:09/10/2019 Source:sciencedirect.com
Summaryd,l-Ethionine produces pancreatic exocrine necrosis and islet proliferation in hamsters and dogs. As a first step in examining whether induction of islet proliferation has therapeutic applications in animals with exhausted or destroyed insulin-producing β-cells, we studied pancreatic pathological alterations after intravenous administration of d,l-ethionine in normal dogs.Histomorphological changes in pancreatic acinar cells and β-cells were assessed in three groups of six clinically normal crossbred dogs administered d,l-ethionine (100 mg/ kg) intravenously three times a week for two weeks. Six additional dogs served as untreated controls. Group I was euthanased and necropsied on day 15 (72 hours after the final dose of ethionine). Groups II and III were euthanased on days 29 and 43 respectively. Severe acinar destruction occurred resulting in significant (p < 0.001) shrinkage of the pancreas in all groups. Although there was variability in histomorphology within groups, pancreases of group I generally exhibited widespread loss of pancreatic acinar structure. Remaining acinar cells were difficult to discern from other cell types within lobules and were surrounded by infiltrates, predominantly of lymphocytes. Partial acinar cellular regeneration had occurred by day 29, but was still incomplete at day 43. Immunohistochemistry suggested that the effect of d,l-ethionine administration on the histomorphology of β-cells in the left lobe was minimal; however, morphometry demonstrated a significant (p < 0.05) increase in the number of individual β-cells in groups II and III, and clusters of 210, 1020 and 20+ cells in Group II. It is probable that the apparent increase in the number of individual and other β-cell arrangements observed in some groups resulted primarily from alterations in the exocrine tissue, although some β-cell hyperplasia cannot be excluded completely.
We also recommend Trading Suppliers and Manufacturers of L-ETHIONINE (cas 13073-35-3). Pls Click Website Link as below: cas 13073-35-3 suppliers
Prev:Cellular proliferation in the canine pancreas after d,L-ETHIONINE (cas 13073-35-3) dosage as detected by double immunohistochemical labelling
Next:Biochemical and developmental features of experimental phenylketonuria induced by L-ETHIONINE (cas 13073-35-3) in suckling rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Altered chemotaxis of Bacillus sphaericus L-ETHIONINE (cas 13073-35-3)-resistant sporulation mutant A probable link between chemotaxis and sporulation09/30/2019
- Effect of L-ETHIONINE (cas 13073-35-3) on macromolecular synthesis in mitogen-stimulated lymphocytes09/29/2019
- Inhibitory effects of N,N′-diphenyl-p-phenylenediamine on the early stage of the enhanced hepatocarcinogenesis caused by coadministration of ethionine and a choline-deficient L-amino acid-defined diet in rats09/28/2019
- In vivo31P NMR studies of the hepatic response to L-ETHIONINE (cas 13073-35-3) in anesthetized rats10/01/2019
- Effect of L-ETHIONINE (cas 13073-35-3) the expression of the SOS system in Escherichia coli09/27/2019
- Acute lethality of D- and L-ETHIONINE (cas 13073-35-3) in Swiss mice09/26/2019
- Short communicationMutagenic effect of L-ETHIONINE (cas 13073-35-3) in soybean and maize☆09/25/2019
- Biochemical and developmental features of experimental phenylketonuria induced by L-ETHIONINE (cas 13073-35-3) in suckling rats09/24/2019
- Cellular proliferation in the canine pancreas after d,L-ETHIONINE (cas 13073-35-3) dosage as detected by double immunohistochemical labelling09/09/2019


